The GSK3A Knockout Ca Ski Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population featuring targeted disruption of the human GSK3A gene within the Ca Ski cervical carcinoma cell line. By abolishing GSK3A function, this model provides a defined knockout background for investigating the kinase??s role in signaling networks and oncogenic processes. The polyclonal format ensures a heterogeneous genetic landscape, minimizing clonal bias and reflecting the average effects of gene loss across a cell pool. This product is designed for rigorous functional genomics and cell signaling studies.
The Ca Ski cell line is an adherent epithelial line isolated from a cervical epidermoid carcinoma. It stably harbors an integrated HPV-16 genome, leading to constitutive expression of the E6 and E7 oncoproteins, which target p53 and retinoblastoma protein for degradation, respectively. This HPV-positive status makes Ca Ski a critical model for studying molecular mechanisms of cervical cancer initiation and progression, including oncogenic signaling, viral-host interactions, and drug sensitivity.
GSK3A encodes glycogen synthase kinase-3 alpha, a constitutively active serine/threonine kinase that serves as a central node in Wnt/??-catenin, PI3K/AKT, insulin, and other signaling cascades. In Wnt signaling, GSK3A resides within the ??-catenin destruction complex alongside Axin, APC, Dishevelled, and FRAT1, phosphorylating ??-catenin to trigger its proteasomal degradation. Wnt ligands such as Wnt3a, through Frizzled and LRP5/6 receptors, inhibit this complex, stabilizing ??-catenin and enabling TCF/LEF-mediated transcription. GSK3A activity is also modulated by AKT-dependent phosphorylation downstream of PI3K and insulin receptor activation. Beyond ??-catenin, GSK3A phosphorylates substrates including glycogen synthase, c-Myc, Cyclin D1, NFAT, CREB, SNAIL, and Tau, thereby regulating metabolism, cell proliferation, apoptosis, and epithelial-mesenchymal transition.
In the Ca Ski background, GSK3A knockout offers a powerful tool to elucidate the kinase??s contribution to HPV-driven oncogenesis. The HPV-16 E6 and E7 oncoproteins perturb PI3K/AKT and Wnt pathways, both of which converge on GSK3A. Loss of GSK3A may alter ??-catenin stability, Cyclin D1 expression, and c-Myc activity, impacting cell cycle progression and apoptosis. Additionally, GSK3A-mediated phosphorylation of SNAIL influences its stability and EMT, suggesting roles in migration and invasion. This model enables dissection of GSK3A-dependent mechanisms in cervical carcinogenesis and evaluation of its potential as a therapeutic target in HPV-positive cancers.
This knockout product is suited for diverse applications in cervical cancer biology, Wnt pathway research, drug target identification, and metabolic signaling. Typical experimental approaches include Western blotting and RT-qPCR for knockout validation, ??-catenin stabilization and TCF/LEF luciferase reporter assays for pathway activity, immunofluorescence for ??-catenin localization, and functional assays for proliferation, migration, and apoptosis. Co-immunoprecipitation can assess destruction complex assembly, and RNA-seq can capture global transcriptomic changes. For detailed protocols or purchasing inquiries, please contact Ascent Research.
